203 Knowledge and awareness of HPV and HPV vaccine among HIV positive women in lagos, nigeria

Sajo, E; Ozonu, Julin; Okunade, Kehinde Sharafadeen; Ejiofor, Janet I.; Adenekan, Muisi A; Amaeshi, LC; Anorlu, Rose

doi:10.1136/ijgc-2019-igcs.203

Cited by 2 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The results of this study indicate that there is a significant lack of knowledge of HPV, cervical cancer, and HPV vaccine among the participants indicating a need for greater public awareness and education about these important health issues. This is similar to a study conducted among WLWH in Lagos, Nigeria where 67.7% of the participants had never heard of HPV infection, and only 22.3% knew about the HPV vaccine (25). Also, in a study conducted in the United States, it was found that HPV vaccine knowledge and awareness were low among WLWH despite their dramatically increased risk of developing pre-cancerous cervical lesions and cervical cancer as well as other types of HPV-associated cancers (26,27).…”

Section: Discussionsupporting

confidence: 87%

“…This finding supports the results of this study, which showed that knowledge of HPV and the vaccine were significant predictors of willingness to pay (45). Another study conducted in Nigeria also identified fear of side effects and lack of trust in the safety and efficacy of the vaccine as important factors contributing to low vaccine uptake and willingness to pay (25,46,47). While education level and income were not strongly associated with willingness to pay for the HPV vaccine, the study found that participants who had attended tertiary education were more willing to pay for the vaccine than those who had not.…”

Section: Discussionmentioning

confidence: 89%

See 1 more Smart Citation

Willingness To Pay for HPV Vaccine Among Women Living With HIV in Nigeria

Akinsolu¹,

Abodunrin²,

Adewole³

et al. 2023

Preprint

View full text Add to dashboard Cite

Background: Human papillomavirus (HPV) is responsible for most cervical cancer cases globally, with women living with HIV at higher risk of persistent HPV infection and HPV-associated disease. The HPV vaccine is a promising solution to reducing cervical cancer rates, but its uptake among women living with HIV in Nigeria is unknown. Methods: A facility-based, cross-sectional survey was conducted with 1,371 women living with HIV to assess their knowledge of HPV, cervical cancer, and the HPV vaccine, as well as their willingness to pay for the vaccine at the HIV treatment clinic, Nigerian Institute of Medical Research, Lagos. Willingness to pay for the HPV vaccine was also assessed. Multivariable logistic regression models were developed to identify factors associated with willingness to pay for the HPV vaccine. Results: The study found that 79.1% of participants had not heard of the vaccine, and only 29.0% knew of its efficacy in preventing cervical cancer. Moreover, 68.3% of participants were unwilling to pay for the vaccine, and the average amount they were willing to pay was low. Knowledge of HPV, the HPV vaccine, cervical cancer, and income were factors associated with willingness to pay for the vaccine. Health workers were the primary source of information. Conclusion: The study found that 79.1% of participants had not heard of the vaccine, and only 29.0% knew of its efficacy in preventing cervical cancer. Moreover, 68.3% of participants were unwilling to pay for the vaccine, and the average amount they were willing to pay was low. Knowledge of HPV, the HPV vaccine, cervical cancer, and income were factors associated with willingness to pay for the vaccine. Health workers were the primary source of information.

show abstract

Section: Discussionsupporting

confidence: 87%

Section: Discussionmentioning

confidence: 89%

Willingness To Pay for HPV Vaccine Among Women Living With HIV in Nigeria

Akinsolu¹,

Abodunrin²,

Adewole³

et al. 2023

Preprint

View full text Add to dashboard Cite

show abstract

“…The results of this study indicate a significant lack of knowledge related to HPV, cervical cancer, and the HPV vaccine among the participants, indicating a need for greater public awareness and education about these critical health issues. This outcome is similar to that of a study conducted among WLWH in Lagos, Nigeria, where 67.7% of the participants had never heard of HPV infection and only 22.3% knew about the HPV vaccine [ 28 ]. Moreover, a study conducted in the United States found that HPV vaccine knowledge and awareness were low among WLWH despite their dramatically increased risk of developing precancerous cervical lesions, cervical cancer, and other HPV-associated cancers [ 26 , 29 ].…”

Section: Discussionsupporting

confidence: 84%

“…This study’s findings support that study’s results, which showed that knowledge of HPV and the vaccine were significant predictors of willingness to pay [ 27 ]. Another study conducted in Nigeria also identified fear of side effects and a lack of trust in the safety and efficacy of the vaccine as essential factors contributing to low vaccine uptake and willingness to pay [ 28 , 47 , 48 ]. According to this study, the perceived benefits of screening are significantly related to the willingness to pay for the HPV vaccine.…”

Section: Discussionmentioning

confidence: 99%

Willingness to Pay for HPV Vaccine among Women Living with HIV in Nigeria

et al. 2023

View full text Add to dashboard Cite

Background: Human papillomavirus (HPV) is responsible for most cervical cancer cases globally, with women living with HIV having a higher risk of persistent HPV infection and HPV-associated disease. The HPV vaccine is a promising tool to reduce cervical cancer rates, but its uptake among women living with HIV in Nigeria is unknown. Methods: A facility-based, cross-sectional survey was conducted with 1371 women living with HIV to assess their knowledge of HPV, cervical cancer, and the HPV vaccine as well as their willingness to pay for the vaccine at the HIV treatment clinic at the Nigerian Institute of Medical Research, Lagos. To identify factors associated with the willingness to pay for the HPV vaccine, multivariable logistic regression models were developed. Results: This study found that 79.1% of participants had not heard of the vaccine, and only 29.0% knew its efficacy in preventing cervical cancer. In addition, 68.3% of participants were unwilling to pay for the vaccine, and the average amount they were willing to pay was low. Knowledge of HPV, the HPV vaccine, and cervical cancer and income were factors associated with the willingness to pay for the vaccine. Health workers were the primary source of information. Conclusions: This study highlights the lack of knowledge and low willingness to pay for the HPV vaccine among women living with HIV in Nigeria and emphasizes the importance of improving education and awareness. Factors associated with the willingness to pay, such as income and knowledge, were identified. Practical strategies, such as community outreach and school-based education programs, could be developed to increase vaccine uptake. Further research is needed to explore additional factors influencing the willingness to pay.

show abstract

203 Knowledge and awareness of HPV and HPV vaccine among HIV positive women in lagos, nigeria

Cited by 2 publications

References 0 publications

Willingness To Pay for HPV Vaccine Among Women Living With HIV in Nigeria

Willingness To Pay for HPV Vaccine Among Women Living With HIV in Nigeria

Willingness to Pay for HPV Vaccine among Women Living with HIV in Nigeria

Contact Info

Product

Resources

About